Market revenue in 2023 | USD 17.5 million |
Market revenue in 2030 | USD 27.6 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Embolic coils |
Fastest growing segment | Aneurysm clips |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Aneurysm clips |
Key market players worldwide | Medtronic PLC, Stryker Corp, Terumo Corp, Johnson & Johnson, Integra Lifesciences Holdings Corp, Penumbra Inc, B. Braun, Balt, Phenox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurovascular embolization devices market will help companies and investors design strategic landscapes.
Embolic coils was the largest segment with a revenue share of 79.43% in 2023. Horizon Databook has segmented the UAE neurovascular embolization devices market based on embolic coils, flow diversion devices, liquid embolic agents, aneurysm clips covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE neurovascular embolization devices market , including forecasts for subscribers. This country databook contains high-level insights into UAE neurovascular embolization devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account